Cargando…
Important Considerations for the Institutional Review Board When Granting Health Insurance Portability and Accountability Act Authorization Waivers
Background: Privacy is recognized as a basic human right in the United States and has been identified as a core principle of ethics in clinical research. However, changes in the regulations, changes in how research is conducted, and the availability of health data stored in electronic health record...
Autores principales: | Williams, Kelsey, Colomb, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Division of Ochsner Clinic Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122251/ https://www.ncbi.nlm.nih.gov/pubmed/32284689 http://dx.doi.org/10.31486/toj.19.0083 |
Ejemplares similares
-
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Pharmacy Benefit: Implications for Health Plans, PBMs, and Providers
por: Walden, Daniel C., et al.
Publicado: (2003) -
Precision Medicine and the Institutional Review Board: Ethics and the Genome
por: Matrana, Marc R., et al.
Publicado: (2020) -
Institutional Review Board Assessment—Balancing Efficiency and Quality
por: Rosenfeld, Stephen J.
Publicado: (2020) -
Implementation of Common Rule Changes to the Informed Consent Form: A Research Staff and Institutional Review Board Collaboration
por: Gartel, Grace, et al.
Publicado: (2020) -
Exemptions and Limited Institutional Review Board Review: A Practical Look at the 2018 Common Rule Requirements for Exempt Research
por: Walch-Patterson, Amelia
Publicado: (2020)